Sunny Pharmtech Inc. (TPEX:6676)
Taiwan · Delayed Price · Currency is TWD 14.75
+1.35 (10.07%)
May 8, 2026, 1:56 PM CST
Sunny Pharmtech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -302.05 | -156 | -63.32 | -170.24 | -174.79 |
Depreciation & Amortization | 127.58 | 119.67 | 118.01 | 108.36 | 103.12 |
Other Amortization | - | 3.35 | 3.21 | 3.33 | 1.74 |
Loss (Gain) From Sale of Assets | 0.13 | -0.08 | 0.08 | 0.09 | - |
Asset Writedown & Restructuring Costs | - | - | 1.24 | - | - |
Loss (Gain) From Sale of Investments | -27.06 | - | - | - | - |
Stock-Based Compensation | 1.48 | 1.37 | 12.63 | 13.07 | 4.17 |
Other Operating Activities | 0.35 | 0.89 | -0.5 | -3.66 | 0.59 |
Change in Accounts Receivable | -15.22 | 7.01 | -27.58 | 34.86 | -24.45 |
Change in Inventory | 43.35 | -26.45 | -25.1 | 25.66 | 42.78 |
Change in Accounts Payable | -8.6 | -9.25 | 13.79 | -10.81 | 6.52 |
Change in Unearned Revenue | 23.05 | 23.36 | 11.05 | 12.9 | 3.68 |
Change in Other Net Operating Assets | -2.01 | -0.96 | -5.41 | 13.31 | 2.29 |
Operating Cash Flow | -158.99 | -37.1 | 38.1 | 26.88 | -34.35 |
Operating Cash Flow Growth | - | - | 41.75% | - | - |
Capital Expenditures | -29.33 | -45.71 | -143.99 | -179.18 | -158.95 |
Sale of Property, Plant & Equipment | - | 0.08 | - | - | - |
Sale (Purchase) of Intangibles | -4.8 | -3.77 | -1.21 | -16.11 | -1.57 |
Investment in Securities | -4.11 | -36.08 | 59.69 | -31.14 | -53.58 |
Other Investing Activities | 0.07 | 0.27 | -0.35 | 4.81 | 0.31 |
Investing Cash Flow | -38.17 | -85.22 | -85.85 | -221.63 | -213.79 |
Short-Term Debt Issued | 143 | 20 | - | 140 | 3.28 |
Long-Term Debt Issued | - | - | 55 | 339 | 290 |
Total Debt Issued | 143 | 20 | 55 | 479 | 293.28 |
Short-Term Debt Repaid | -20 | - | -190 | - | - |
Long-Term Debt Repaid | -24.92 | -31.61 | -50.64 | -290.18 | -310.99 |
Total Debt Repaid | -44.92 | -31.61 | -240.64 | -290.18 | -310.99 |
Net Debt Issued (Repaid) | 98.08 | -11.61 | -185.64 | 188.82 | -17.71 |
Issuance of Common Stock | 8.82 | 1.4 | 281.32 | - | 252.7 |
Other Financing Activities | - | - | - | -0.44 | 0.44 |
Financing Cash Flow | 106.9 | -10.21 | 95.67 | 188.38 | 235.43 |
Net Cash Flow | -90.26 | -132.53 | 47.92 | -6.37 | -12.71 |
Free Cash Flow | -188.32 | -82.81 | -105.88 | -152.3 | -193.31 |
Free Cash Flow Margin | -74.43% | -19.81% | -24.69% | -42.35% | -80.21% |
Free Cash Flow Per Share | -1.27 | -0.56 | -0.74 | -1.10 | -1.45 |
Cash Interest Paid | - | 9.07 | 11.24 | 8.26 | 5.62 |
Cash Income Tax Paid | - | 0.3 | 0.5 | -0.01 | -0.02 |
Levered Free Cash Flow | -72.31 | -46.2 | -91.48 | -118.38 | -157.65 |
Unlevered Free Cash Flow | -65.84 | -40.54 | -84.45 | -115.52 | -154.14 |
Change in Working Capital | 40.58 | -6.3 | -33.25 | 75.92 | 30.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.